{"name":"Newron Sweden AB","slug":"newron-sweden-ab","ticker":"","exchange":"","domain":"","description":"Newron Sweden AB is a biotechnology company focused on the development of innovative treatments for neurological and psychiatric disorders. Despite having a portfolio of three drug candidates, all are currently in a discontinued phase, indicating a shift in the company's strategic focus or challenges in advancing these programs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNMDJUU1owcWM2YV9kM3JyWU92SW4zTHpJN0V6dXRqdlhyZEdSclBNOXN0WDZlZnl6MThGbmFvTVQ1YTZJVS1FYjJYT3BFeHdnN0ZxY0RsRUIyM1ZYWjN3bWRYWXF2MlNjQU5BVTJwQlBlVktuajN1M3lPSzdKNVZVMTljMi1pSERhR2lzTGJyMGdSMVdYU1pzN25jRzRKcG9LeVRrbHkyS2dSTkR1N09Dd3BmcVVhYW13V1I0cXc1VjZ4LUFsWk1sTlR5eVhxRW4zVElXVC1semdjMUlrY2RPcU5vbnVZV1Y4NEJNYtIB8gFBVV95cUxNM2llNzJHS0EtSkRyb1gwVldNcEQ3Mzd3ZzBEZW54R3hXLWJIbUxISU1nVFl5WlhjbWFGX0hjNWU1cmIwaldSSUNDZkVNaWdqOXZFOGRZNjZZZll0T3pOT2FQZk9fbWJWeDR6LTB5bFVyWmNrVVNWRDU0eUlfckZLTkpfNWtPMFFSVmdTYTJvdDdOcDNQbndDZnJrYXZmTWdUbUpzRWtqSUsxSDVRaWxBUy1pNTd4eVdoczF5UGhRQThaQ2dIVHp5bzNHdTM2cV8tSlRiVVUxTjU0Y1VfWFNKUkJsTkoycXIzYmpQUHJFdjBCdw?oc=5","date":"2026-01-12","type":"pipeline","source":"simplywall.st","summary":"3 European Growth Stocks With Up To 31% Insider Ownership - simplywall.st","headline":"3 European Growth Stocks With Up To 31% Insider Ownership","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}